JPH08511684A - 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ - Google Patents
熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼInfo
- Publication number
- JPH08511684A JPH08511684A JP7501963A JP50196395A JPH08511684A JP H08511684 A JPH08511684 A JP H08511684A JP 7501963 A JP7501963 A JP 7501963A JP 50196395 A JP50196395 A JP 50196395A JP H08511684 A JPH08511684 A JP H08511684A
- Authority
- JP
- Japan
- Prior art keywords
- cleavage
- oligonucleotide
- dna
- sequence
- polymerase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 101710163270 Nuclease Proteins 0.000 title claims abstract description 139
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 title claims description 127
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 title claims description 120
- 238000003776 cleavage reaction Methods 0.000 claims abstract description 273
- 230000007017 scission Effects 0.000 claims abstract description 240
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 100
- 238000000034 method Methods 0.000 claims abstract description 96
- 102000004190 Enzymes Human genes 0.000 claims abstract description 91
- 108090000790 Enzymes Proteins 0.000 claims abstract description 91
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 73
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 73
- 108091034117 Oligonucleotide Proteins 0.000 claims description 203
- 230000000694 effects Effects 0.000 claims description 158
- 108020004414 DNA Proteins 0.000 claims description 116
- 102000053602 DNA Human genes 0.000 claims description 113
- 238000001514 detection method Methods 0.000 claims description 81
- 230000000295 complement effect Effects 0.000 claims description 78
- 239000002773 nucleotide Substances 0.000 claims description 74
- 125000003729 nucleotide group Chemical group 0.000 claims description 71
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 49
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 45
- 239000007787 solid Substances 0.000 claims description 42
- 239000013598 vector Substances 0.000 claims description 31
- 238000012217 deletion Methods 0.000 claims description 24
- 230000037430 deletion Effects 0.000 claims description 24
- 241000589499 Thermus thermophilus Species 0.000 claims description 23
- 241000589500 Thermus aquaticus Species 0.000 claims description 17
- 238000000137 annealing Methods 0.000 claims description 16
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 239000007795 chemical reaction product Substances 0.000 claims description 14
- 230000006820 DNA synthesis Effects 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 12
- 230000004075 alteration Effects 0.000 claims description 12
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 6
- 108020004511 Recombinant DNA Proteins 0.000 claims description 5
- 230000000692 anti-sense effect Effects 0.000 claims description 3
- 238000003780 insertion Methods 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 2
- 230000002452 interceptive effect Effects 0.000 abstract description 4
- 238000001668 nucleic acid synthesis Methods 0.000 abstract 1
- 239000013615 primer Substances 0.000 description 135
- 238000006243 chemical reaction Methods 0.000 description 126
- 108090000623 proteins and genes Proteins 0.000 description 115
- 229940088598 enzyme Drugs 0.000 description 91
- 239000000047 product Substances 0.000 description 69
- 239000000523 sample Substances 0.000 description 69
- 239000000758 substrate Substances 0.000 description 66
- 102000004169 proteins and genes Human genes 0.000 description 56
- 238000009396 hybridization Methods 0.000 description 50
- 238000003556 assay Methods 0.000 description 48
- 238000012360 testing method Methods 0.000 description 43
- 238000003752 polymerase chain reaction Methods 0.000 description 38
- 239000000872 buffer Substances 0.000 description 36
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 33
- 239000012634 fragment Substances 0.000 description 33
- 239000011324 bead Substances 0.000 description 31
- 239000000203 mixture Substances 0.000 description 28
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 26
- 239000000499 gel Substances 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 23
- 230000003321 amplification Effects 0.000 description 21
- 238000003199 nucleic acid amplification method Methods 0.000 description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 239000000284 extract Substances 0.000 description 19
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 18
- 230000027455 binding Effects 0.000 description 18
- 230000035772 mutation Effects 0.000 description 18
- 108010041758 cleavase Proteins 0.000 description 17
- 239000006228 supernatant Substances 0.000 description 17
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 16
- 108010010677 Phosphodiesterase I Proteins 0.000 description 15
- 230000014509 gene expression Effects 0.000 description 15
- 238000011534 incubation Methods 0.000 description 15
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 14
- 241000589596 Thermus Species 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 238000007792 addition Methods 0.000 description 13
- 239000004202 carbamide Substances 0.000 description 13
- 239000000427 antigen Substances 0.000 description 12
- 108091007433 antigens Proteins 0.000 description 12
- 102000036639 antigens Human genes 0.000 description 12
- 230000001419 dependent effect Effects 0.000 description 12
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 210000003000 inclusion body Anatomy 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 238000010586 diagram Methods 0.000 description 11
- 229910001629 magnesium chloride Inorganic materials 0.000 description 11
- 229920002401 polyacrylamide Polymers 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- 108700028369 Alleles Proteins 0.000 description 10
- 241000588724 Escherichia coli Species 0.000 description 10
- 238000000211 autoradiogram Methods 0.000 description 10
- 238000001962 electrophoresis Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 244000052769 pathogen Species 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- 108091026890 Coding region Proteins 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 238000010367 cloning Methods 0.000 description 9
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 9
- 239000000975 dye Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 9
- 238000006116 polymerization reaction Methods 0.000 description 9
- 108091008146 restriction endonucleases Proteins 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 108010068698 spleen exonuclease Proteins 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 8
- 238000002372 labelling Methods 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 7
- 108010006785 Taq Polymerase Proteins 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 7
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 7
- 239000002751 oligonucleotide probe Substances 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 108010042407 Endonucleases Proteins 0.000 description 6
- 238000000376 autoradiography Methods 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 230000037048 polymerization activity Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000005382 thermal cycling Methods 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- 102100031780 Endonuclease Human genes 0.000 description 5
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 5
- 229920001213 Polysorbate 20 Polymers 0.000 description 5
- 101710137500 T7 RNA polymerase Proteins 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 239000012148 binding buffer Substances 0.000 description 5
- 239000004327 boric acid Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000009089 cytolysis Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000009977 dual effect Effects 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000006166 lysate Substances 0.000 description 5
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000002285 radioactive effect Effects 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
- 241001112695 Clostridiales Species 0.000 description 4
- 108010017826 DNA Polymerase I Proteins 0.000 description 4
- 102000004594 DNA Polymerase I Human genes 0.000 description 4
- 108060002716 Exonuclease Proteins 0.000 description 4
- 229920002873 Polyethylenimine Polymers 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 4
- 229960005542 ethidium bromide Drugs 0.000 description 4
- 102000013165 exonuclease Human genes 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 239000012139 lysis buffer Substances 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 230000005291 magnetic effect Effects 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 3
- 108090000994 Catalytic RNA Proteins 0.000 description 3
- 102000053642 Catalytic RNA Human genes 0.000 description 3
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 3
- 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 3
- 230000004543 DNA replication Effects 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102100034343 Integrase Human genes 0.000 description 3
- UASDAHIAHBRZQV-YUMQZZPRSA-N Met-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N UASDAHIAHBRZQV-YUMQZZPRSA-N 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000017854 proteolysis Effects 0.000 description 3
- 239000011535 reaction buffer Substances 0.000 description 3
- 108091092562 ribozyme Proteins 0.000 description 3
- 102220201851 rs143406017 Human genes 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 108020005544 Antisense RNA Proteins 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 241000701832 Enterobacteria phage T3 Species 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 101710203526 Integrase Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 230000007022 RNA scission Effects 0.000 description 2
- 241000205180 Thermococcus litoralis Species 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 238000004581 coalescence Methods 0.000 description 2
- 239000003184 complementary RNA Substances 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000005546 dideoxynucleotide Substances 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000009585 enzyme analysis Methods 0.000 description 2
- 238000012869 ethanol precipitation Methods 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000003269 fluorescent indicator Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000009830 intercalation Methods 0.000 description 2
- 230000000155 isotopic effect Effects 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N pentofuranose Chemical group OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- -1 polyoxy Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- BHNQPLPANNDEGL-UHFFFAOYSA-N 2-(4-octylphenoxy)ethanol Chemical compound CCCCCCCCC1=CC=C(OCCO)C=C1 BHNQPLPANNDEGL-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 101710098119 Chaperonin GroEL 2 Proteins 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 102000004214 DNA polymerase A Human genes 0.000 description 1
- 108090000725 DNA polymerase A Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 238000012270 DNA recombination Methods 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000702224 Enterobacteria phage M13 Species 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241000834713 Gogo Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
- 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
- 108010054278 Lac Repressors Proteins 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 108010059724 Micrococcal Nuclease Proteins 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 102100027069 Odontogenic ameloblast-associated protein Human genes 0.000 description 1
- 101710091533 Odontogenic ameloblast-associated protein Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010076039 Polyproteins Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000205160 Pyrococcus Species 0.000 description 1
- 239000013616 RNA primer Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 241000205188 Thermococcus Species 0.000 description 1
- 241000206213 Thermosipho africanus Species 0.000 description 1
- 241000204652 Thermotoga Species 0.000 description 1
- 241000589497 Thermus sp. Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 101150067977 ap gene Proteins 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 210000004671 cell-free system Anatomy 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000003936 denaturing gel electrophoresis Methods 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000001036 exonucleolytic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002875 fluorescence polarization Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 108010055863 gene b exonuclease Proteins 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 238000012933 kinetic analysis Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 229940059904 light mineral oil Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001718 repressive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000012622 synthetic inhibitor Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- NLIVDORGVGAOOJ-MAHBNPEESA-M xylene cyanol Chemical compound [Na+].C1=C(C)C(NCC)=CC=C1C(\C=1C(=CC(OS([O-])=O)=CC=1)OS([O-])=O)=C\1C=C(C)\C(=[NH+]/CC)\C=C/1 NLIVDORGVGAOOJ-MAHBNPEESA-M 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/682—Signal amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6823—Release of bound markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 熱安定性DNAポリメラーゼをコードするDNA配列であって、天然DNAポリメ ラーゼのものから変更されたDNA合成活性を示すように天然配列に対して配列に おいて変更されている前記DNA配列。 2. コードされたDNAポリメラーゼが天然DNAポリメラーゼのものよりも減少し た合成活性を示す、請求項1のDNA配列。 3. 前記天然配列に対する変更が単一のヌクレオチドの変化を含む請求項1の DNA配列。 4. 前記天然配列に対する変更が欠失を含む請求項1のDNA配列。 5. 配列番号9〜12及び21からなる群から選択されるDNA配列を含む請求項4 のDNA配列。 6. 前記天然配列に対する変更が挿入を含む請求項1のDNA配列。 7. Thermus aquaticus、Thermus flavus及びThermus thermophilusからなる 群から選択された生物を起源とする請求項2のDNA配列。 8. 天然DNAポリメラーゼのものから変更されたDNA合成活性を示すように天然 配列に対して配列において変更されている熱安定性DNAポリメラーゼをコードす るDNA配列を含む組換え体DNAベクター。 9. 前記天然配列に対する変更が単一のヌクレオチドの変化を含む請求項8の DNA配列を含む組換え体DNAベクター。 10. 前記天然配列に対する変更が欠失を含む請求項8のDNA配列を含む組換え 体DNAベクター。 11. Thermus aquaticus、Thermus flavus及びThermus thermophilusからなる 群から選択された生物を起源とする請求項8のDNA配列を含む組換え体DNAベクタ ー。 12. 配列番号9〜12及び21からなる群から選択されるDNA配列を含む請求項11 のDNA配列を含む組換え体DNAベクター。 13. 請求項8の組換え体ベクターで形質転換された宿主細胞。 14. 天然DNAポリメラーゼのものから変更されたDNA合成活性を示すが、天然DN Aポリメラーゼのものと実質的に同じ5'ヌクレアーゼ活性を保持するようにアミ ノ酸配列において変更された熱安定性DNAポリメラーゼ。 15. 変更されたポリメラーゼが天然DNAポリメラーゼのものよりも減少した合 成活性を示す請求項14のポリメラーゼ。 16. 前記天然配列に対する変更がアミノ酸の変化を含む請求項15のポリメラー ゼ。 17. 前記天然配列に対する変更が欠失を含む請求項15のポリメラーゼ。 18. Thermus aquaticus、Thermus flavus及びThermus thermophilusからなる 群から選択された生物を起源とする請求項15のポリメラーゼ。 19. 配列番号9〜12及び21からなる群から選択される核酸配列によりコードさ れるアミノ酸配列を含む請求項18のポリメラーゼ。 20. 特異的なターゲットDNA分子の存在を検出する方法であって、 a) i) ターゲット核酸、 ii) 前記ターゲット核酸の第1の部分に相補的な第1のオリゴヌクレオチ ド、及び iii) 第2のオリゴヌクレオチドであって、そのある領域が前記ターゲット 核酸の第2の部分に相補的であり、該第2のオリゴヌクレオチドの非相補的領域 がその5'末端において一重鎖アームを提供するものである前記第2のオリゴヌク レオチドを用意し、 b) 前記ターゲット核酸、前記第1のオリゴヌクレオチド及び前記第2のオリゴ ヌクレオチドを、前記第1のオリゴヌクレオチドと前記第2のオリゴヌクレオチ ドの3'末端が前記ターゲットDNA配列にアニールして第1の開裂構造を生成する ような条件下で混合し、 c) 前記第1の開裂構造の開裂が前記第2のオリゴヌクレオチド内に位置する部 位において前記第1及び第2のオリゴヌクレオチドの前記ターゲット核酸上への アニーリングに依存するかたちで優先的に起こるような条件下で開裂手段を提供 し、これにより前記第2のオリゴヌクレオチドの一重鎖アームを遊離して第3の オリゴヌクレオチドを生成し、 d) 一重鎖3'アーム及び一重鎖5'アームを有する第1のヘアピン構造を、前記第 3のオリゴヌクレオチドが前記第1のヘアピンの一重鎖3'アームにアニールし、 これにより第2の開裂構造を生成するような条件下に提供し、 e) 前記開裂手段により前記第2の開裂構造の開裂が起こり、前記第2の開裂構 造の一重鎖5'アームが遊離され、第4のオリゴヌ クレオチドと第1の開裂されたヘアピン検出分子を含む反応生成物を生成する条 件を提供し、 f) 一重鎖3'アーム及び一重鎖5'アームを有する第2のヘアピン構造を、前記第 4のオリゴヌクレオチドが前記第2のヘアピンの一重鎖3'アームにアニールし、 これにより第3の開裂構造を生成するような条件下に提供し、 g) 前記開裂手段により前記第3の開裂構造の開裂が起こり、前記第3の開裂構 造の一重鎖5'アームが遊離され、配列において前記第3のオリゴヌクレオチドと 同一の第5のオリゴヌクレオチドと第2の開裂されたヘアピン検出分子を含む反 応生成物を生成する条件を提供し、 h) 前記第1及び第2の開裂されたヘアピン検出分子の存在を検出することを含 む前記方法。 21. 段階d)〜g)を少なくとも1回繰り返す請求項20の方法。 22. 前記開裂手段が変更された熱安定性DNAポリメラーゼを含み、開裂反応が 有意なポリメラーゼ活性の不存在下におこる請求項20の方法。 23. 前記第1のオリゴヌクレオチド、前記第3のオリゴヌクレオチド及び前記 第4のオリゴヌクレオチドのアニールの不存在下には段階c)、e)及びg)の開裂反 応がそれぞれ起こらない請求項20の方法。 24. 段階c)の開裂反応が前記第2のオリゴヌクレオチドのアニールした部分内 で起こる請求項20の方法。 25. 段階c)の開裂反応が前記第2のオリゴヌクレオチドのアニールしていない 部分内で起こる請求項20の方法。 26. 特異的なターゲット核酸分子の存在を検出する方法であって、 a) i) 開裂手段、 ii) ターゲット核酸、 iii) 前記ターゲット核酸の第1の部分に相補的な第1のオリゴヌクレオチ ド、 iv) そのある領域が前記ターゲット核酸の第2の部分に相補的である第2 のオリゴヌクレオチドを有する第1の固体支持体であって、前記第2のオリゴヌ クレオチドの非相補的領域がその5'末端において一重鎖アームを提供し、前記5' アームが第1のシグナルオリゴヌクレオチドを含むもの、 v) そのある領域が前記第1のシグナルオリゴヌクレオチドに相補的であ る第3のオリゴヌクレオチドをそれぞれ有する複数の開裂されていない第2の固 体支持体であって、前記第3のオリゴヌクレオチドの非相補的領域がその5'末端 において一重鎖アームを提供し、前記5'アームの部分が第2のシグナルオリゴヌ クレオチドを含むもの、及び vi) そのある領域が前記第2のシグナルオリゴヌクレオチドに相補的であ る第4のオリゴヌクレオチドをそれぞれ有する複数の開裂されていない第3の固 体支持体であって、前記第4のオリゴヌクレオチドの非相補的領域がその5'末端 において一重鎖アームを提供し、前記5'アームの部分が前記第1のシグナルオリ ゴヌクレオチドを含むもの、を用意し、 b) 前記開裂手段、前記ターゲット核酸、前記第1のオリゴヌクレオチド及び前 記第2のオリゴヌクレオチドを、前記第1のオリ ゴヌクレオチドと前記第2のオリゴヌクレオチドの3'末端が前記ターゲットDNA 配列にアニールして第1の開裂構造を生成し、前記第1の開裂構造の開裂により 前記第1のシグナルオリゴヌクレオチドが遊離されるような条件下で混合し、 c) 前記遊離された第1のシグナルオリゴヌクレオチドを前記複数の第2の固体 支持体の1つと、前記第1のシグナルオリゴヌクレオチドが前記第3のオリゴヌ クレオチドの前記相補的領域にハイブリダイズして第2の開裂構造を生成し、前 記第2の開裂構造の開裂が前記第2のシグナルオリゴヌクレオチドと開裂された 第2の固体支持体の遊離をもたらすような条件下で反応させ、 d) 前記遊離された第2のシグナルオリゴヌクレオチドを前記複数の第3の固体 支持体の1つと、前記第2のシグナルオリゴヌクレオチドが前記第4のオリゴヌ クレオチドの前記相補的領域にハイブリダイズして第3の開裂構造を生成し、前 記第3の開裂構造の開裂が前記第1のシグナルオリゴヌクレオチドの第2の分子 と開裂された第3の固体支持体の遊離をもたらすような条件下で反応させ、 e) 前記第1及び第2のシグナルオリゴヌクレオチドの存在を検出することを含 む前記方法。 27. 前記開裂手段が熱安定性DNAポリメラーゼから誘導された5'ヌクレアーゼ を含む請求項26の方法。 28. 前記熱安定性DNAポリメラーゼが、Thermus aquaticus、Thermus flavus及 びThermus thermophilusからなる群から選択された生物から誘導される請求項27 の方法。 29. 前記5'ヌクレアーゼが配列番号11、30及び31からなる群か ら選択されるDNA配列によりコードされている請求項28の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/073,384 US5541311A (en) | 1992-12-07 | 1993-06-04 | Nucleic acid encoding synthesis-deficient thermostable DNA polymerase |
US08/073,384 | 1993-06-04 | ||
PCT/US1994/006253 WO1994029482A1 (en) | 1993-06-04 | 1994-06-06 | 5' nucleases derived from thermostable dna polymerase |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006109102A Division JP4016050B2 (ja) | 1993-06-04 | 2006-04-11 | 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ |
JP2007259968A Division JP4451476B2 (ja) | 1993-06-04 | 2007-10-03 | 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH08511684A true JPH08511684A (ja) | 1996-12-10 |
Family
ID=22113384
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7501963A Withdrawn JPH08511684A (ja) | 1993-06-04 | 1994-06-06 | 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ |
JP2006109102A Expired - Lifetime JP4016050B2 (ja) | 1993-06-04 | 2006-04-11 | 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ |
JP2007259968A Expired - Lifetime JP4451476B2 (ja) | 1993-06-04 | 2007-10-03 | 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ |
JP2009138740A Pending JP2009232854A (ja) | 1993-06-04 | 2009-06-10 | 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006109102A Expired - Lifetime JP4016050B2 (ja) | 1993-06-04 | 2006-04-11 | 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ |
JP2007259968A Expired - Lifetime JP4451476B2 (ja) | 1993-06-04 | 2007-10-03 | 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ |
JP2009138740A Pending JP2009232854A (ja) | 1993-06-04 | 2009-06-10 | 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ |
Country Status (10)
Country | Link |
---|---|
US (3) | US5541311A (ja) |
EP (2) | EP1505160B1 (ja) |
JP (4) | JPH08511684A (ja) |
AT (2) | ATE274587T1 (ja) |
AU (1) | AU694736B2 (ja) |
CA (2) | CA2320666C (ja) |
DE (2) | DE69435030T2 (ja) |
DK (1) | DK1505160T3 (ja) |
ES (1) | ES2293141T3 (ja) |
WO (1) | WO1994029482A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009232854A (ja) * | 1993-06-04 | 2009-10-15 | Third Wave Technologies Inc | 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ |
Families Citing this family (173)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1223831A (en) | 1982-06-23 | 1987-07-07 | Dean Engelhardt | Modified nucleotides, methods of preparing and utilizing and compositions containing the same |
US5846717A (en) * | 1996-01-24 | 1998-12-08 | Third Wave Technologies, Inc. | Detection of nucleic acid sequences by invader-directed cleavage |
US7150982B2 (en) * | 1991-09-09 | 2006-12-19 | Third Wave Technologies, Inc. | RNA detection assays |
US7045289B2 (en) * | 1991-09-09 | 2006-05-16 | Third Wave Technologies, Inc. | Detection of RNA Sequences |
US6759226B1 (en) | 2000-05-24 | 2004-07-06 | Third Wave Technologies, Inc. | Enzymes for the detection of specific nucleic acid sequences |
US6872816B1 (en) * | 1996-01-24 | 2005-03-29 | Third Wave Technologies, Inc. | Nucleic acid detection kits |
US5994069A (en) * | 1996-01-24 | 1999-11-30 | Third Wave Technologies, Inc. | Detection of nucleic acids by multiple sequential invasive cleavages |
US7601496B2 (en) * | 1992-12-07 | 2009-10-13 | Third Wave Technologies, Inc. | Cleavage of nucleic acids |
US5843654A (en) * | 1992-12-07 | 1998-12-01 | Third Wave Technologies, Inc. | Rapid detection of mutations in the p53 gene |
US6372424B1 (en) | 1995-08-30 | 2002-04-16 | Third Wave Technologies, Inc | Rapid detection and identification of pathogens |
US6673616B1 (en) * | 1992-12-07 | 2004-01-06 | Third Wave Technologies, Inc. | Methods and compositions for characterizing nucleic acids |
US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
US5547859A (en) * | 1993-08-02 | 1996-08-20 | Goodman; Myron F. | Chain-terminating nucleotides for DNA sequencing methods |
US6406855B1 (en) | 1994-02-17 | 2002-06-18 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
WO1996014405A2 (en) * | 1994-11-04 | 1996-05-17 | Molecular Biology Resources, Inc. | Biologically active fragments of thermus flavus dna polymerase |
CA2203627C (en) * | 1994-11-09 | 2000-06-06 | James E. Dahlberg | Rapid detection and identification of nucleic acid variants and pathogens |
ES2185719T3 (es) * | 1994-12-23 | 2003-05-01 | Dade Behring Inc | Deteccion de acidos nucleicos por formacion de un producto catalizada por diana. |
DE19525632C2 (de) * | 1995-07-14 | 1997-07-17 | Bag Biolog Analysensystem Gmbh | Sequenzspezifisches Nukleinsäurenachweisverfahren und Reagenz-System zu dessen Durchführung |
US7527928B2 (en) * | 1996-11-29 | 2009-05-05 | Third Wave Technologies, Inc. | Reactions on a solid surface |
US6913881B1 (en) | 1996-01-24 | 2005-07-05 | Third Wave Technologies, Inc. | Methods and compositions for detecting target sequences |
ES2317113T3 (es) * | 1996-01-24 | 2009-04-16 | Third Wave Tech Inc | Escision invasiva de acidos nucleicos. |
US7122364B1 (en) * | 1998-03-24 | 2006-10-17 | Third Wave Technologies, Inc. | FEN endonucleases |
US6875572B2 (en) | 1996-01-24 | 2005-04-05 | Third Wave Technologies, Inc. | Nucleic acid detection assays |
US7195871B2 (en) * | 1996-01-24 | 2007-03-27 | Third Wave Technologies, Inc | Methods and compositions for detecting target sequences |
US20080160524A1 (en) * | 1996-01-24 | 2008-07-03 | Third Wave Technologies, Inc. | Methods and Compositions for Detecting Target Sequences |
US6706471B1 (en) | 1996-01-24 | 2004-03-16 | Third Wave Technologies, Inc. | Detection of nucleic acid sequences by invader-directed cleavage |
US20080220425A1 (en) * | 1996-01-24 | 2008-09-11 | Third Wave Technologies, Inc. | Methods and Compositions for Detecting Target Sequences |
US6090606A (en) * | 1996-01-24 | 2000-07-18 | Third Wave Technologies, Inc. | Cleavage agents |
US5985557A (en) | 1996-01-24 | 1999-11-16 | Third Wave Technologies, Inc. | Invasive cleavage of nucleic acids |
US7432048B2 (en) * | 1996-11-29 | 2008-10-07 | Third Wave Technologies, Inc. | Reactions on a solid surface |
US6140053A (en) * | 1996-11-06 | 2000-10-31 | Sequenom, Inc. | DNA sequencing by mass spectrometry via exonuclease degradation |
EP0966542B1 (en) * | 1996-11-29 | 2008-11-12 | Third Wave Technologies, Inc. | Fen-1 endonucleases, mixtures and cleavage methods |
EP2208789B1 (en) * | 1997-03-12 | 2015-07-22 | Applied Biosystems, LLC | DNA polymerases having improved labeled nucleotide incorporation properties |
ATE557103T1 (de) | 1997-05-30 | 2012-05-15 | Trovagene Inc | Verfahren zur erkennung von nukleinsäuresequenzen in urin |
US7056703B2 (en) * | 1997-08-06 | 2006-06-06 | Diversa Corporation | Polypeptides having polymerase activity and methods of use thereof |
US7049101B1 (en) | 1997-08-06 | 2006-05-23 | Diversa Corporation | Enzymes having high temperature polymerase activity and methods of use thereof |
US8182991B1 (en) | 1997-11-26 | 2012-05-22 | Third Wave Technologies, Inc. | FEN-1 endonucleases, mixtures and cleavage methods |
US7090975B2 (en) | 1998-03-13 | 2006-08-15 | Promega Corporation | Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection |
US6703211B1 (en) | 1998-03-13 | 2004-03-09 | Promega Corporation | Cellular detection by providing high energy phosphate donor other than ADP to produce ATP |
US6159693A (en) * | 1998-03-13 | 2000-12-12 | Promega Corporation | Nucleic acid detection |
US6391551B1 (en) | 1998-03-13 | 2002-05-21 | Promega Corporation | Detection of nucleic acid hybrids |
US6235480B1 (en) * | 1998-03-13 | 2001-05-22 | Promega Corporation | Detection of nucleic acid hybrids |
US6312902B1 (en) | 1998-03-13 | 2001-11-06 | Promega Corporation | Nucleic acid detection |
US6270973B1 (en) | 1998-03-13 | 2001-08-07 | Promega Corporation | Multiplex method for nucleic acid detection |
US6268146B1 (en) | 1998-03-13 | 2001-07-31 | Promega Corporation | Analytical methods and materials for nucleic acid detection |
US6270974B1 (en) | 1998-03-13 | 2001-08-07 | Promega Corporation | Exogenous nucleic acid detection |
DE69940430D1 (de) | 1998-06-24 | 2009-04-02 | Illumina Inc | Dekodierung von matrixartig-angeordneten Sensoren durch Mikropartikel |
US6593084B2 (en) | 1998-10-13 | 2003-07-15 | Robert E. Bird | Carcinogen assay |
HK1040795B (en) * | 1998-11-27 | 2003-12-24 | Synaptics (Uk) Limited | position sensor |
US6355431B1 (en) * | 1999-04-20 | 2002-03-12 | Illumina, Inc. | Detection of nucleic acid amplification reactions using bead arrays |
US20060275782A1 (en) | 1999-04-20 | 2006-12-07 | Illumina, Inc. | Detection of nucleic acid reactions on bead arrays |
AU4476900A (en) | 1999-04-20 | 2000-11-02 | Illumina, Inc. | Detection of nucleic acid reactions on bead arrays |
US20030207295A1 (en) * | 1999-04-20 | 2003-11-06 | Kevin Gunderson | Detection of nucleic acid reactions on bead arrays |
AU5008900A (en) * | 1999-05-12 | 2000-11-21 | Invitrogen Corporation | Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
US8481268B2 (en) | 1999-05-21 | 2013-07-09 | Illumina, Inc. | Use of microfluidic systems in the detection of target analytes using microsphere arrays |
US8080380B2 (en) * | 1999-05-21 | 2011-12-20 | Illumina, Inc. | Use of microfluidic systems in the detection of target analytes using microsphere arrays |
US7118860B2 (en) * | 1999-10-29 | 2006-10-10 | Stratagene California | Methods for detection of a target nucleic acid by capture |
US7824859B2 (en) * | 1999-10-29 | 2010-11-02 | Cytyc Corporation | Methods for detection of a target nucleic acid by forming a cleavage structure using an RNA polymerase |
US7838225B2 (en) * | 1999-10-29 | 2010-11-23 | Hologic, Inc. | Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase |
US6893819B1 (en) * | 2000-11-21 | 2005-05-17 | Stratagene California | Methods for detection of a nucleic acid by sequential amplification |
US6423535B1 (en) | 1999-11-24 | 2002-07-23 | Incyte Genomics, Inc. | Normalization control for hybridization reactions |
AU4507201A (en) * | 1999-11-24 | 2001-06-18 | Incyte Genomics, Inc. | Normalization controls and duplex probes for hybridization reactions |
US7611869B2 (en) * | 2000-02-07 | 2009-11-03 | Illumina, Inc. | Multiplexed methylation detection methods |
US8076063B2 (en) | 2000-02-07 | 2011-12-13 | Illumina, Inc. | Multiplexed methylation detection methods |
US6812005B2 (en) | 2000-02-07 | 2004-11-02 | The Regents Of The University Of California | Nucleic acid detection methods using universal priming |
WO2001057269A2 (en) * | 2000-02-07 | 2001-08-09 | Illumina, Inc. | Nucleic acid detection methods using universal priming |
US7582420B2 (en) | 2001-07-12 | 2009-09-01 | Illumina, Inc. | Multiplex nucleic acid reactions |
US7955794B2 (en) * | 2000-09-21 | 2011-06-07 | Illumina, Inc. | Multiplex nucleic acid reactions |
US20050214825A1 (en) * | 2000-02-07 | 2005-09-29 | John Stuelpnagel | Multiplex sample analysis on universal arrays |
US7361488B2 (en) * | 2000-02-07 | 2008-04-22 | Illumina, Inc. | Nucleic acid detection methods using universal priming |
ATE412774T1 (de) | 2000-02-16 | 2008-11-15 | Illumina Inc | Parallele genotypisierung mehrerer patientenproben |
EP1366192B8 (en) * | 2000-10-24 | 2008-10-29 | The Board of Trustees of the Leland Stanford Junior University | Direct multiplex characterization of genomic dna |
US20040018491A1 (en) * | 2000-10-26 | 2004-01-29 | Kevin Gunderson | Detection of nucleic acid reactions on bead arrays |
US20030092157A1 (en) * | 2001-03-16 | 2003-05-15 | Hayden Michael R. | Compositions, screening systems and methods for modulating HDL cholesterol and triglyceride levels |
CA2448484A1 (en) * | 2001-05-25 | 2002-12-05 | Xenon Genetics, Inc. | Diagnostic methods for cardiovascular disease, low hdl-cholesterol levels, and high triglyceride levels |
EP1404824A2 (en) | 2001-07-06 | 2004-04-07 | Amersham Biosciences Corp. | Novel dna polymerases having amino acid substitutions and homologs thereof |
EP1481076A4 (en) | 2001-07-12 | 2005-05-11 | Illumina Inc | MULTIPLEX NUCLEIC REACTIONS |
US20050042629A1 (en) | 2002-09-13 | 2005-02-24 | Applera Corporation | Thermus scotoductus nucleic acid polymerases |
EP1466013A4 (en) * | 2001-09-14 | 2006-09-06 | Applera Corp | NUCLEIC ACID POLYMERASES FROM THERMUS SCOTODUCTUS |
JP2005508630A (ja) * | 2001-09-14 | 2005-04-07 | インヴィトロジェン コーポレーション | Dnaポリメラーゼとその変異体 |
WO2003035671A2 (en) * | 2001-10-24 | 2003-05-01 | Singulex, Inc. | Methods for detecting genetic haplotypes by interaction with probes |
WO2003048307A2 (en) * | 2001-11-30 | 2003-06-12 | Applera Corporation | Thermus igniterrae nucleic acid polymerases |
US7052877B2 (en) | 2001-11-30 | 2006-05-30 | Applera Corporation | Thermus brockianus nucleic acid polymerases |
US20030180741A1 (en) | 2001-12-21 | 2003-09-25 | Holly Hogrefe | High fidelity DNA polymerase compositions and uses therefor |
AU2003208959A1 (en) * | 2002-01-30 | 2003-09-02 | Id Biomedical Corporation | Methods for detecting vancomycin-resistant microorganisms and compositions therefor |
GB0205455D0 (en) | 2002-03-07 | 2002-04-24 | Molecular Sensing Plc | Nucleic acid probes, their synthesis and use |
WO2003089654A2 (en) * | 2002-04-22 | 2003-10-30 | Wisconsin Alumni Research Foundation | Single nucleotide polymorphism analysis using surface invasive cleavage reactions |
US20040096871A1 (en) * | 2002-11-14 | 2004-05-20 | Molly Accola | CFTR allele detection assays |
US7312033B2 (en) * | 2002-11-14 | 2007-12-25 | Third Wave Technologies, Inc. | CFTR allele detection assays |
US20060147938A1 (en) * | 2002-11-14 | 2006-07-06 | Third Wave Technologies, Inc. | CFTR allele detection assays |
US20060003333A1 (en) * | 2002-11-19 | 2006-01-05 | Singulex, Inc. | Preparation of defined highly labeled probes |
ATE525469T1 (de) | 2002-12-18 | 2011-10-15 | Third Wave Tech Inc | Nachweis kleiner nukleinsäuren |
US8206904B2 (en) * | 2002-12-18 | 2012-06-26 | Third Wave Technologies, Inc. | Detection of nucleic acids |
US7700750B2 (en) * | 2003-01-09 | 2010-04-20 | Third Wave Technologies, Inc. | Connexin allele detection assays |
CA2513985C (en) * | 2003-01-21 | 2012-05-29 | Illumina Inc. | Chemical reaction monitor |
US20040161749A1 (en) * | 2003-01-24 | 2004-08-19 | Hall Jeff G. | 3' end tagged oligonucleotides |
US6943768B2 (en) | 2003-02-21 | 2005-09-13 | Xtellus Inc. | Thermal control system for liquid crystal cell |
ATE459710T1 (de) * | 2003-03-25 | 2010-03-15 | Stratagene California | Dna-polymerasefusionen und deren verwendungen |
US20040259100A1 (en) | 2003-06-20 | 2004-12-23 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
WO2005019419A2 (en) * | 2003-07-31 | 2005-03-03 | Singulex, Inc. | Co-detection of single polypeptide and polynucleotide molecules |
US20050136414A1 (en) * | 2003-12-23 | 2005-06-23 | Kevin Gunderson | Methods and compositions for making locus-specific arrays |
US7473773B2 (en) | 2004-01-07 | 2009-01-06 | Third Wave Technologies, Inc. | Determination of hepatitis C virus genotype |
US7417133B2 (en) * | 2004-02-27 | 2008-08-26 | Institut Pasteur | Methods for obtaining thermostable enzymes, DNA polymerase I variants from Thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same |
EP1574583A1 (en) * | 2004-03-10 | 2005-09-14 | Roche Diagnostics GmbH | Methods for isolation of bacteria from biological samples |
CN101189347A (zh) * | 2005-05-03 | 2008-05-28 | 通信探索公司 | 反转探针及其用于核酸检测的用途 |
JP2008539761A (ja) * | 2005-05-11 | 2008-11-20 | ストラタジーン カリフォルニア | スナップバックオリゴヌクレオチドプローブ |
US20080014124A1 (en) * | 2005-08-04 | 2008-01-17 | Third Wave Technologies, Inc. | Sample processing devices, systems and methods |
US7482127B2 (en) * | 2005-11-03 | 2009-01-27 | Third Wave Technologies, Inc. | Nucleic acid detection assays employing blocker oligonucleotides |
US20070207455A1 (en) * | 2005-11-17 | 2007-09-06 | Third Wave Technologies, Inc. | Compositions and methods for detecting an HCV-1 subtype |
US7981606B2 (en) * | 2005-12-21 | 2011-07-19 | Roche Molecular Systems, Inc. | Control for nucleic acid testing |
CA2650820C (en) | 2006-04-28 | 2014-09-16 | Igor Kutyavin | Use of base-modified deoxynucleoside triphosphates to improve nucleic acid detection |
WO2007127999A2 (en) * | 2006-04-28 | 2007-11-08 | Igor Kutyavin | Use of products of pcr amplification carrying elements of secondary structure to improve pcr-based nucleic acid detection |
US20080125333A1 (en) * | 2006-05-31 | 2008-05-29 | Antara Biosciences Inc. | Devices and kits for detecting one or more target agents |
EP2029774B1 (en) | 2006-06-01 | 2015-04-01 | Third Wave Technologies, Inc. | Detection of nucleic acids |
US20080131875A1 (en) * | 2006-06-07 | 2008-06-05 | Third Wave Technologies, Inc. | Multiplex assays |
US7759062B2 (en) * | 2006-06-09 | 2010-07-20 | Third Wave Technologies, Inc. | T-structure invasive cleavage assays, consistent nucleic acid dispensing, and low level target nucleic acid detection |
US8080643B2 (en) * | 2006-09-05 | 2011-12-20 | Third Wave Technologies, Inc. | HPV primers |
US8445238B2 (en) * | 2006-10-04 | 2013-05-21 | Third Wave Technologies, Inc. | Snap-back primers and detectable hairpin structures |
PT2033641E (pt) | 2007-08-01 | 2012-04-10 | Ferlux | Processo de preparação de extractos ricos em proantocianidinas |
US20090253142A1 (en) | 2008-03-15 | 2009-10-08 | Hologic, Inc. | Compositions and methods for analysis of nucleic acid molecules during amplification reactions |
JP2009268665A (ja) * | 2008-05-07 | 2009-11-19 | Canon Inc | 吸入装置 |
WO2009155271A1 (en) * | 2008-06-17 | 2009-12-23 | Sigma-Aldrich Co. | Real time polymerase chain reaction process using a universal detection system |
EP2853601B1 (en) | 2008-07-18 | 2016-09-21 | TrovaGene, Inc. | Methods for PCR-based detection of "ultra short" nucleic acid sequences |
WO2010030716A1 (en) * | 2008-09-10 | 2010-03-18 | Igor Kutyavin | Detection of nucleic acids by oligonucleotide probes cleaved in presence of endonuclease v |
EP2483425B1 (en) | 2009-09-28 | 2016-08-24 | Igor Kutyavin | Methods and compositions for detection of nucleic acids based on stabilized oligonucleotide probe complexes |
WO2012046140A1 (en) | 2010-10-05 | 2012-04-12 | Finnzymes Oy | Enzyme mixture |
US8916344B2 (en) | 2010-11-15 | 2014-12-23 | Exact Sciences Corporation | Methylation assay |
US8361720B2 (en) | 2010-11-15 | 2013-01-29 | Exact Sciences Corporation | Real time cleavage assay |
US8715937B2 (en) | 2010-11-15 | 2014-05-06 | Exact Sciences Corporation | Mutation detection assay |
MX352460B (es) | 2011-01-11 | 2017-11-24 | Seegene Inc | Detección de secuencias de ácido nucleico objetivo mediante ensayo de escisión y extensión del pto. |
US11078525B2 (en) | 2011-03-29 | 2021-08-03 | Seegene, Inc. | Detection of target nucleic acid sequence by PTO cleavage and extension-dependent cleavage |
MX342067B (es) | 2011-05-04 | 2016-09-09 | Seegene Inc | Detección de secuencias de ácido nucleico objetivo por desdoblamiento e hibridización de oligonucleótido de sonda. |
US9850524B2 (en) | 2011-05-04 | 2017-12-26 | Seegene, Inc. | Detection of target nucleic acid sequences by PO cleavage and hybridization |
US10059984B2 (en) | 2011-06-16 | 2018-08-28 | The Regents Of The University Of California | Salt-tolerant DNA polymerases |
US9127318B2 (en) | 2011-10-18 | 2015-09-08 | Exact Sciences Corporation | Multiplexed KRAS mutation detection assay |
KR20130101952A (ko) | 2012-02-02 | 2013-09-16 | 주식회사 씨젠 | Pto 절단과 연장-의존적 혼성화를 이용한 타겟 핵산서열의 검출 |
KR101794981B1 (ko) | 2012-03-05 | 2017-11-09 | 주식회사 씨젠 | Pto 절단 및 연장 어세이에 의한 타겟 핵산서열에서의 뉴클레오타이드 변이 검출 |
WO2013187628A1 (en) * | 2012-06-11 | 2013-12-19 | Seegene, Inc. | Detection of target nucleic acid sequence by pto cleavage and extension-dependent transcription |
EP2943586B1 (en) | 2012-12-27 | 2017-09-20 | Seegene, Inc. | Detection of target nucleic acid sequence by pto cleavage and extension-dependent non-hybridization assay |
EP2770065B1 (en) | 2013-02-25 | 2017-12-13 | Seegene, Inc. | Detection of nucleotide variation on target nucleic acid sequence |
WO2014158628A1 (en) | 2013-03-14 | 2014-10-02 | Hologic, Inc. | Compositions and methods for analysis of nucleic acid molecules |
EP2971112A2 (en) | 2013-03-15 | 2016-01-20 | TrovaGene, Inc. | Detection of nucleic acids in urine |
EP3022319B1 (en) | 2013-07-15 | 2023-05-17 | Seegene, Inc. | Detection of target nucleic acid sequence by pto cleavage and extension-dependent immobilized oligonucleotide hybridization |
WO2015016612A1 (en) * | 2013-07-31 | 2015-02-05 | Seegene, Inc. | Method for determining snp genotype |
EP3058105B1 (en) | 2013-10-18 | 2019-05-22 | Seegene, Inc. | Detection of target nucleic acid sequence on solid phase by pto cleavage and extension using hcto assay |
WO2015147370A1 (en) | 2014-03-28 | 2015-10-01 | Seegene, Inc. | Detection of target nucleic acid sequences using different detection temperatures |
EP3289103B1 (en) | 2015-05-01 | 2021-10-06 | Gen-Probe Incorporated | Multiplex invasive cleavage assays |
CN108368547B (zh) | 2015-12-15 | 2022-04-05 | Seegene株式会社 | 与靶核酸序列有关的信号提取 |
WO2017213458A1 (en) | 2016-06-10 | 2017-12-14 | Seegene, Inc. | Methods for preparing tagging oligonucleotides |
CN109689884A (zh) | 2016-09-15 | 2019-04-26 | 豪夫迈·罗氏有限公司 | 用于进行多重实时pcr的方法 |
KR102239375B1 (ko) | 2016-10-06 | 2021-04-13 | 주식회사 씨젠 | 시료 내 타겟 핵산분자의 검출에 이용되는 올리고뉴클레오타이드의 제공방법 |
RU2665631C2 (ru) | 2017-01-25 | 2018-09-03 | Общество с ограниченной ответственностью "Секвойя Дженетикс" | Способ специфической идентификации последовательностей днк |
KR102270849B1 (ko) | 2017-03-28 | 2021-06-29 | 주식회사 씨젠 | 타겟 핵산 서열의 존재를 결정하기 위한 분석 시그널 |
CN108823287B (zh) | 2017-04-28 | 2019-04-12 | 厦门大学 | 一种检测靶核酸序列的方法 |
US10995104B2 (en) | 2017-05-30 | 2021-05-04 | Roche Molecular System, Inc. | Catalysts for reversing formaldehyde adducts and crosslinks |
WO2019026884A1 (ja) | 2017-07-31 | 2019-02-07 | 凸版印刷株式会社 | 核酸検出方法および検出用試薬 |
CA3072452A1 (en) | 2017-08-11 | 2019-02-14 | Gen-Probe Incorporated | Compositions and methods for detecting staphylococcus aureus |
EP3676400A4 (en) | 2017-08-31 | 2021-06-02 | Seegene, Inc. | Evaluation of performance of components using a pair of dimer-forming primers |
EP3676615B1 (en) * | 2017-08-31 | 2022-08-03 | SOMAprobes SL | Lateral flow assay for detecting the presence of a specific mammalian cell or bacteria in a biological sample |
CA3229263A1 (en) | 2017-09-28 | 2019-04-04 | Seegene, Inc. | Method and device for analyzing target analyte in sample |
KR102345601B1 (ko) | 2017-09-29 | 2021-12-30 | 주식회사 씨젠 | Pto 절단 및 연장-의존적 연장 분석에 의한 타겟 핵산 서열의 검출 |
US11662281B2 (en) | 2017-12-13 | 2023-05-30 | Gen-Probe Incorporated | Compositions and methods for biological sample processing |
JP2021506274A (ja) | 2017-12-15 | 2021-02-22 | ジェン−プローブ・インコーポレーテッド | 毒素産生Clostridium difficileを検出するための組成物および方法 |
WO2019135567A1 (en) | 2018-01-05 | 2019-07-11 | Seegene, Inc. . | Method for determining the presence or absence of m. tuberculosis, m. bovis and m. bovis bcg in a sample |
JP7170062B2 (ja) | 2018-04-20 | 2022-11-11 | シージーン アイエヌシー | サンプル内複数のターゲット核酸配列の検出のための方法及び装置 |
US20220025449A1 (en) | 2018-12-14 | 2022-01-27 | Seegene, Inc. | Method for detecting a target analyte in a sample using an s-shaped function for a slope data set |
WO2020154513A1 (en) | 2019-01-25 | 2020-07-30 | Gen-Probe Incorporated | Detection of drug-resistant mycoplasma genitalium |
EP4403645A1 (en) | 2021-09-17 | 2024-07-24 | Seegene, Inc. | Detection of target nucleic acid sequence by using synthetic non-natural base-bearing tag oligonucleotide |
CN118103522A (zh) | 2021-09-30 | 2024-05-28 | 简·探针公司 | 可温度选择的fret盒信号传导 |
US20230348957A1 (en) | 2021-12-07 | 2023-11-02 | Luminex Corporation | Methods and compositions for nucleic acid analysis |
WO2024054924A1 (en) | 2022-09-08 | 2024-03-14 | Gen-Probe Incorporated | Method of detecting nucleic acid analytes using dual-specificity primers |
WO2024106890A1 (ko) | 2022-11-16 | 2024-05-23 | 주식회사 씨젠 | 퀀칭-pto 절단 및 연장(quenching-pto cleavage and extension; q-ptoce) 어세이에 의한 타겟 핵산의 검출 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US5011769A (en) * | 1985-12-05 | 1991-04-30 | Meiogenics U.S. Limited Partnership | Methods for detecting nucleic acid sequences |
AU623642B2 (en) * | 1988-03-24 | 1992-05-21 | University Of Iowa Research Foundation, The | Catalytic hybridization systems for the detection of nucleic acid sequences based on their activity as cofactors in catalytic reactions in which a complementary labeled nucleic acid probe is cleaved |
US5144019A (en) * | 1989-06-21 | 1992-09-01 | City Of Hope | Ribozyme cleavage of HIV-I RNA |
US5108892A (en) * | 1989-08-03 | 1992-04-28 | Promega Corporation | Method of using a taq dna polymerase without 5'-3'-exonuclease activity |
AU646430B2 (en) * | 1989-12-22 | 1994-02-24 | F. Hoffmann-La Roche Ag | Recombinant expression vectors and purification methods for thermus thermophilus DNA polymerase |
GB9009903D0 (en) * | 1990-05-02 | 1990-06-27 | Ici Plc | Assay for specific nucleic acid sequences |
US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
EP0550687B1 (en) * | 1990-09-28 | 1999-06-09 | F. Hoffmann-La Roche Ag | 5' to 3' exonuclease mutations of thermostable dna polymerases |
US6083686A (en) * | 1990-10-26 | 2000-07-04 | Johnson & Johnson Clinical Diagnostic Systems, Inc. | Increased production of Thermus aquaticus DNA polymerase in E. coli |
US5541311A (en) * | 1992-12-07 | 1996-07-30 | Third Wave Technologies, Inc. | Nucleic acid encoding synthesis-deficient thermostable DNA polymerase |
US5422253A (en) * | 1992-12-07 | 1995-06-06 | Wisconsin Alumni Research Foundation | Method of site specific nucleic acid cleavage |
-
1993
- 1993-06-04 US US08/073,384 patent/US5541311A/en not_active Expired - Lifetime
-
1994
- 1994-06-06 DE DE69435030T patent/DE69435030T2/de not_active Expired - Lifetime
- 1994-06-06 EP EP04020089A patent/EP1505160B1/en not_active Expired - Lifetime
- 1994-06-06 DK DK04020089T patent/DK1505160T3/da active
- 1994-06-06 DE DE69433966T patent/DE69433966D1/de not_active Expired - Lifetime
- 1994-06-06 CA CA002320666A patent/CA2320666C/en not_active Expired - Lifetime
- 1994-06-06 CA CA002163015A patent/CA2163015C/en not_active Expired - Lifetime
- 1994-06-06 AT AT94919345T patent/ATE274587T1/de not_active IP Right Cessation
- 1994-06-06 EP EP94919345A patent/EP0711361B1/en not_active Expired - Lifetime
- 1994-06-06 JP JP7501963A patent/JPH08511684A/ja not_active Withdrawn
- 1994-06-06 WO PCT/US1994/006253 patent/WO1994029482A1/en active IP Right Grant
- 1994-06-06 AT AT04020089T patent/ATE373726T1/de active
- 1994-06-06 ES ES04020089T patent/ES2293141T3/es not_active Expired - Lifetime
- 1994-06-06 AU AU70520/94A patent/AU694736B2/en not_active Expired
-
1995
- 1995-06-06 US US08/481,238 patent/US5795763A/en not_active Expired - Lifetime
- 1995-06-06 US US08/483,043 patent/US5691142A/en not_active Expired - Lifetime
-
2006
- 2006-04-11 JP JP2006109102A patent/JP4016050B2/ja not_active Expired - Lifetime
-
2007
- 2007-10-03 JP JP2007259968A patent/JP4451476B2/ja not_active Expired - Lifetime
-
2009
- 2009-06-10 JP JP2009138740A patent/JP2009232854A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009232854A (ja) * | 1993-06-04 | 2009-10-15 | Third Wave Technologies Inc | 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ |
Also Published As
Publication number | Publication date |
---|---|
ATE373726T1 (de) | 2007-10-15 |
CA2163015A1 (en) | 1994-12-22 |
EP1505160B1 (en) | 2007-09-19 |
EP0711361B1 (en) | 2004-08-25 |
JP2006296425A (ja) | 2006-11-02 |
EP1505160A3 (en) | 2005-05-04 |
JP4016050B2 (ja) | 2007-12-05 |
EP1505160A2 (en) | 2005-02-09 |
AU7052094A (en) | 1995-01-03 |
WO1994029482A1 (en) | 1994-12-22 |
JP2009232854A (ja) | 2009-10-15 |
CA2320666A1 (en) | 1994-12-22 |
US5795763A (en) | 1998-08-18 |
DE69433966D1 (en) | 2004-09-30 |
EP0711361A4 (en) | 1998-04-15 |
DE69435030D1 (de) | 2007-10-31 |
EP0711361A1 (en) | 1996-05-15 |
DE69435030T2 (de) | 2008-06-12 |
JP4451476B2 (ja) | 2010-04-14 |
ES2293141T3 (es) | 2008-03-16 |
DK1505160T3 (da) | 2008-01-28 |
US5541311A (en) | 1996-07-30 |
US5691142A (en) | 1997-11-25 |
ATE274587T1 (de) | 2004-09-15 |
AU694736B2 (en) | 1998-07-30 |
CA2163015C (en) | 2001-11-20 |
CA2320666C (en) | 2007-06-05 |
JP2008054686A (ja) | 2008-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH08511684A (ja) | 熱安定性dnaポリメラーゼ由来の5’ヌクレアーゼ | |
US5614402A (en) | 5' nucleases derived from thermostable DNA polymerase | |
US5719028A (en) | Cleavase fragment length polymorphism | |
US5843654A (en) | Rapid detection of mutations in the p53 gene | |
US5888780A (en) | Rapid detection and identification of nucleic acid variants | |
US6372424B1 (en) | Rapid detection and identification of pathogens | |
JP4362150B2 (ja) | Fen−1エンドヌクレアーゼ、混合物、および開裂方法 | |
JP4295715B2 (ja) | 核酸の侵入的開裂 | |
US5871911A (en) | Method of site-specific nucleic acid cleavage | |
US7067643B2 (en) | Systems for the detection of target sequences | |
CZ293215B6 (cs) | Rekombinantní tepelně stálá DNA polymeráza, způsob její přípravy a prostředek, který ji obsahuje | |
JP2001518805A (ja) | 多重逐次侵入的開裂による核酸の検出 | |
US7785852B2 (en) | Cleavage of nucleic acids | |
JPH11506932A (ja) | 点変異の検出及びインビトロ突然変異誘発のための核酸修復酵素方法 | |
AU4444699A (en) | Rapid detection and indentification of nucleic acid variants and pathogens | |
AU4058802A (en) | Rapid detection and identification of nucleic acid variants and pathogens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040120 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040301 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040421 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051011 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060105 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060220 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060411 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061010 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20061226 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070219 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070410 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070605 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20071114 |